Founded in March 2016, CRISM Therapeutics employs an interdisciplinary team of pharmaceutical specialists based in Birmingham. We serve a wide range of international clients, aiming to improve the clinical performance of active pharmaceutical ingredients (APIs) via local drug delivery and personalised medicines.
CEO: |
Andrew James Webb |
Non-Executive Chairman: |
Nermeen Yunus Varawalla |
Independent Non-Executive Director: |
Gerald Beaney |
Chief Scientific Officer: |
Christopher McConville |
Address: |
Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands, USA |
Phone: |
+1 (925) 408 4621 |
Fax: |
|
Website: |
http://www.crismtherapeutics.com/ |
Email: |
|